Finance

Stock futures slip as Wall Street wraps up first week of second-quarter earnings

In this article

Scott Mlyn | CNBC

Futures contracts tied to the U.S. stock indexes slipped during the overnight session Thursday evening as Wall Street neared the end of the first major week of second-quarter earnings reports.

Contracts linked to the S&P 500 lost 0.1%, while Dow futures lost 32 points. Nasdaq 100 futures shed less than 0.1%.

The moves in the overnight session came as investors pored over the first batch of second-quarter earnings reports published throughout the week.

Though some of the nation’s largest lenders posted healthy profits and revenues amid the economic recovery, the reaction in the stock market has been less than rosy. Morgan Stanley’s second-quarter earnings report, for example, topped analysts’ expectations Thursday, yet its shares closed just 0.18% higher.

For the 18 S&P 500 companies that beat analyst estimates for second-quarter earnings this week, the average earnings-per-share result was 18% higher than expected. But those companies saw their shares fall 0.58% on average after reporting.

The muted moves in reaction to corporate earnings have contributed to an equally lackluster week for the S&P 500, which has dipped 0.2% so far this week.

Much of the market’s upward pressure over the last week has come from a handful of mega-cap internet and communications stocks. Apple is up 2.3% since the week began, while Netflix, Alphabet and Microsoft are all up at least 1.1%.

Wall Street may be checking its optimism in the aftermath of the recent hot consumer price index inflation report and commentary from both Federal Reserve Chairman Jerome Powell and Treasury Secretary Janet Yellen about the pace of price appreciation.

Yellen, who spoke to CNBC’s “Closing Bell” on Thursday, said she predicts prices could continue to rise for several more months before cooling off.

“I’m not saying that this is a one-month phenomenon. But I think over the medium term, we’ll see inflation decline back toward normal levels,” she said. “But, of course, we have to keep a careful eye on it.”

Become a smarter investor with CNBC Pro
Get stock picks, analyst calls, exclusive interviews and access to CNBC TV. 
Sign up to start a free trial today

Products You May Like

Leave a Reply

Your email address will not be published. Required fields are marked *